Vimarsana
Biggest News Aggregation in the World

Functional Outcomes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Functional Outcomes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Functional Outcomes Today - Breaking & Trending Today

External ventricular drainage timing in traumatic brain injury may result in better long-term functional outcomes - Vimarsana News

External ventricular drainage timing in traumatic brain injury may result in better long-term functional outcomes

A study in the Journal of Neurotrauma shows that in patients with moderate to severe traumatic brain injury (TBI) that need an external ventricular drain (EVD) insertion to control intracranial hypertension, early (<24-hours post-injury) insertion may result in better long-term functional outcomes.

Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy - Vimarsana News

Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy

Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure therapy reduced risks of death and hospitalization for patients with obstructive sleep...

Sleep Apnea Research Shows PAP's Impact on Health Outcomes - Vimarsana News

Sleep Apnea Research Shows PAP's Impact on Health Outcomes

Research presented at ATS 2024 highlights the clinical benefits of PAP therapy in treating sleep-disordered breathing.

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy - Vimarsana News

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy

AXS-12 statistically significantly reduced cataplexy attacks compared to placebo AXS-12 achieved statistically significant remission of cataplexy compared to placebo AXS-12 statistically...

AXS-12 Reduces Narcolepsy Symptoms in Phase 3 Trial - Vimarsana News

AXS-12 Reduces Narcolepsy Symptoms in Phase 3 Trial

Axsome Therapeutics announced topline trial results, which show AXS-12 significantly improves key narcolepsy symptoms.